Medidata’s journey started in 1999 when a scientist working on his first clinical trial waded through inefficiencies and delays, and knew that technology could improve the process. Over time, we’ve grown to be the leader in clinical technology, with thousands of people working towards the same goal: using the latest technology to help our life science clients bring their life-saving new treatments to the public.As the global impact of COVID-19 increases, Medidata is continuously analyzing its effect on patient study enrollment, the response by world regulatory bodies and which Medidata’s solutions can help address your COVID 19-related challenges.The fireside chat will be focused on learning more about one of Medidata’s co-founders, Glen de Vries. Glen will discuss Medidata’s evolution and use of technology. Additionally, Glen will discuss approaches to meeting regulatory requirements and what he sees as emerging risks across the industry over the next few years.Audience:
Fees: This virtual event is free for members, students, and non-members. Speakers: Guest of Honor:Mr. Glen de Vries - Co-CEO of Medidata SolutionsModerator/ Host:Mr. David NicklesISACA New York Chapter Corporate Relation Committee chairDate/Time:Tuesday, December 15, 2020, 10 am-11 am US ESTFormat:Fireside chatDuration:1-hour (1 CPE available)
954 Lexington Ave#525New York, NY 10021-5013
Contact Chapter
JoinBenefitsCredentials
Contact ISACA Global Support
About ISACACommunity Code of ConductISACA Policies ISACA Terms of UseISACA Global Privacy Notice
Chapter Privacy Policy